Soft Tissue Neoplasms

"Soft Tissue Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

Descriptor ID	D012983
MeSH Number(s)	C04.588.839
Concept/Terms	Soft Tissue Neoplasms Soft Tissue Neoplasms Neoplasm, Soft Tissue Neoplasms, Soft Tissue Soft Tissue Neoplasm

Below are MeSH descriptors whose meaning is more general than "Soft Tissue Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Soft Tissue Neoplasms [C04.588.839]

Below are MeSH descriptors whose meaning is related to "Soft Tissue Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Soft Tissue Neoplasms".

Soft Tissue Neoplasms
Muscle Neoplasms
Vascular Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Soft Tissue Neoplasms" by people in this website by year, and whether "Soft Tissue Neoplasms" was a major or minor topic of these publications.

Bar chart showing 179 publications over 30 distinct years, with a maximum of 11 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	4	1	5
1997	3	1	4
1998	9	0	9
1999	8	1	9
2000	4	0	4
2001	7	2	9
2002	3	0	3
2003	4	0	4
2004	3	1	4
2005	9	0	9
2006	9	0	9
2007	7	2	9
2008	4	3	7
2009	5	2	7
2010	5	1	6
2011	3	0	3
2012	6	0	6
2013	6	0	6
2014	5	0	5
2015	8	0	8
2016	2	0	2
2017	7	0	7
2018	2	1	3
2019	5	0	5
2020	5	1	6
2021	7	1	8
2022	5	0	5
2023	11	0	11
2024	4	1	5
2025	1	0	1

Below are the most recent publications written about "Soft Tissue Neoplasms" by people in Profiles.

Wei S, Patchefsky AS, Pei J, Brown SA, Basu Mallick A, Wang Z, Jiang W. PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature. Am J Clin Pathol. 2025 Feb 12; 163(2):224-230.

View in: PubMed
Warmke LM, Ameline B, Fritchie KJ, Dehner CA, Agaimy A, Din NU, Miettinen MM, Dermawan JK, Gross JM, Thangaiah JJ, Chrisinger JSA, Suster DI, Perret R, Le Loarer F, Charville GW, Buehler D, Yeung MCF, Smith BF, Baumhoer D, Davis JL. YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma. Virchows Arch. 2025 Mar; 486(3):457-477.

View in: PubMed
Montreuil J, Kholodovsky E, Markowitz M, Torralbas Fitz S, Campano D, Geiger E, Hornicek F, Crawford B, Keisch M, Temple HT. Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications. J Surg Oncol. 2025 Apr; 131(5):965-975.

View in: PubMed
Garza-B?ez P, Allison SJ, Nazarian LN. Approach to Evaluating Superficial Soft Tissue Masses by Ultrasound. Radiol Clin North Am. 2025 Jan; 63(1):109-122.

View in: PubMed
Montreuil J, Campano D, Montoya-Cerrillo D, Subhawong T, Geiger EJ, Rosenberg AE, Temple TH. Large Nodular Fasciitis of the Shoulder Presenting as Soft Tissue Sarcoma: A Case Report. JBJS Case Connect. 2024 Jul 01; 14(3).

View in: PubMed
Cocchi S, Gambarotti M, Gamberi G, Magagnoli G, Maioli M, Stevanin M, Samperi F, Righi A, Benini S. The utility of FISH analysis in the diagnosis of BCOR-rearranged sarcomas. Pathol Res Pract. 2024 Mar; 255:155209.

View in: PubMed
Wood ML, Fanburg-Smith JC, Brian JM, White JC, Powell JL, Freiberg AS. Successful Crizotinib-targeted Therapy of Pediatric Unresectable ERC1::ALK Fusion Sarcoma. J Pediatr Hematol Oncol. 2024 03 01; 46(2):e184-e187.

View in: PubMed
Mancarella C, Morrione A, Scotlandi K. PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas. Int J Mol Sci. 2023 Nov 15; 24(22).

View in: PubMed
Miettinen M, Abdullaev Z, Turakulov R, Quezado M, Lui?a Contreras A, Curcio CA, Rys J, Chlopek M, Lasota J, Aldape KD. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. Am J Surg Pathol. 2024 Jan 01; 48(1):112-122.

View in: PubMed
Lasota J, Chlopek M, Kaczorowski M, Nat?lie K, Rys J, Kopczynski J, Sulaieva O, Michal M, Kruczak A, Harazin-Lechowska A, Szczepaniak M, Koshyk O, Halon A, Czapiewski P, Abdullaev Z, Kowalik A, Aldape KD, Michal M, Miettinen M. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. Am J Surg Pathol. 2024 Jan 01; 48(1):97-105.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement